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1998 HD Summary 
 
Since 1980, SCWDS has conducted an annual 
mail survey of state fish and wildlife agencies and 
other selected sources to determine the activity of 
hemorrhagic disease (HD) in wild deer and other 
big game in the continental United States.  HD is 
caused by either the epizootic hemorrhagic 
disease (EHD) or bluetongue viruses and is the 
most important infectious disease syndrome 
known in white-tailed deer.  The Final Report for 
the 1998 Hemorrhagic Disease (HD) Surveillance 
Questionnaire has been completed and sent to all 
cooperators.  Wildlife biologists and wildlife 
health scientists reported that 24 states had HD 
activity in a total of 327 counties.  Deer die-offs 
were reported in Arkansas, Illinois, Iowa, Kansas, 
Kentucky, Missouri, Nebraska, South Dakota, 
Tennessee, Virginia, and Washington.  
Substantial death losses occurred in Illinois, Iowa, 
Kentucky, Missouri, Nebraska, and Tennessee.  
Several other states have reported focal losses or 
evidence of convalescent cases (Alabama, 
Indiana, Maryland, Mississippi, North Carolina, 
Oklahoma, South Carolina, Texas, and Virginia). 
 
Eighteen isolations of EHD virus serotype 2 
(EHDV-2) were made at SCWDS from August to 
November 1998.  Nine isolations were made from 
samples submitted from Missouri; 8 from white-
tailed deer and 1 from a cow.  Of the 8 Missouri 
deer, 2 were wild and 6 were captive.  Isolations 
of EHDV-2 also were made from samples 
submitted from 3 white-tailed deer from 
Tennessee, 1 from Kansas, and 1 from Virginia.  
All of these were from free-ranging animals.  The 
remaining isolations came from captive white-
tailed deer and included 1 submission from 
Arkansas and 1 from Oklahoma.  Presence of 
EHDV-2 virus genetic material in affected white-
tailed deer, which is detected by the polymerase 
chain reaction (PCR) test, was reported for Iowa 
and Missouri by state and federal veterinarians 
who made additional investigations. 
 
Last year (1998) will be remembered for the 
numerous cases of clinical disease in cattle that 
were attributable to EHDV.  These cattle had 
fever, inappetence, lameness, and oral erosions.  
Several diagnostic investigations linked the 
problem in cattle with EHDV-2 by use of 
serology to demonstrate antibodies or the PCR 
test to show viral RNA in the blood.  However, 
the only virus isolation from a bovine was the 
aforementioned EHDV-2 from a cow in Missouri.  
Wildlife managers should be prepared for 
increased speculation on the importance of deer 
to the health status of cattle as awareness of 
EHDV in cattle develops among farmers. 
 
At this time, we would like to thank all of the 
people who participated in the HD survey and/or 
submitted virus isolates or samples for virus 
isolation during 1998.  Copies of the Final Report 
are available by request to SCWDS.  (Prepared by 
Victor Nettles and David Stallknecht) 
 
HD Virus Isolation Support 
 
SCWDS provides diagnostic support to our 
cooperating agencies through virus isolations of 
epizootic hemorrhagic disease virus (EHDV) and 
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bluetongue virus (BTV), which are the agents that 
cause hemorrhagic disease (HD) in deer.  Since 
1990, SCWDS has isolated over 70 EHDV-2 
viruses as well as several EHDV-1 viruses and a 
BT-10 virus from samples submitted throughout 
the Southeast and Midwest.  With the exception 
of last year's EHDV-2 isolation from a Missouri 
cow, all of these viruses have come from white-
tailed deer. 
 
Our virus isolation attempts involve inoculation 
of material from a suspect animal into cell 
cultures, and we utilize both baby hamster kidney 
(BHK21) and cattle pulmonary artery endothelial 
(CPAE) cell lines.  These cell lines are available 
from the American Type Culture Collection, 
Rockville, MD.  With either cell line, two 7-day 
passages are done.  During 1998, 16 of our 
samples were completed in both cell lines.  For 
these 16 virus isolation attempts, EHDV-2 was 
isolated on the CPAE cell line in all cases, while 
the virus was isolated in BHK21 cells from only 4.  
Similar results were obtained during 1996 when 
15 EHDV-2 isolations were made from cases in 
which both cell lines were utilized.  Of these 15, 
virus was isolated from 14 attempts in CPAE 
cells but only 5 in BHK21 cells.  Although it is 
apparent from the above results that the CPAE 
cell line offers a much more sensitive EHDV-2 
isolation system than BHK21, we recommend that 
both cell lines be used.  Had not the BHK21 cell 
line been used in 1996, we would have missed an 
EHDV-2 isolation from Indiana and an EHDV-1 
isolation from Tennessee.   Considering the 
scarcity of EHDV-1 isolates during recent years, 
this would have been a significant loss.  Another 
consideration in utilizing the CPAE cell line is the 
fact that this cell line has been reported to be 
persistently infected with bovine viral diarrhea 
virus.  This may render this cell line unsuitable 
for use in some diagnostic laboratories and may 
complicate the use of CPAE-derived virus 
isolations for future experimental work. 
 
We would like to thank all of you who submitted 
both virus isolates and samples for virus isolation 
during 1998.  These isolations not only help to 
confirm specific outbreaks, but it is hoped that 
they also will provide the necessary biological 
material for future experimental work to truly 
understand the pathogenesis and epidemiology of 
these viruses. 
 
With the 1999 HD season (late summer and fall) 
approaching, we would like to offer the following 
guidelines for submitting samples for virus 
isolation: 
  1. Call SCWDS or the state or federal 
diagnostic laboratory that you wish to use 
if you have a suspected HD case.  Virus 
isolation protocols vary among 
laboratories, and it is often necessary for 
the laboratory to prepare cells for virus 
isolation in advance. 
  2. Tissues collected should include spleen 
and, if available from a live animal, 
unclotted blood.  The blood should be 
collected in an anticoagulant such as 
EDTA, citrate, or heparin.  Anticoagulant 
tubes can be obtained from veterinarians or 
medical laboratories.  HD viruses can be 
isolated from other tissues including lung, 
lymph node, bone marrow, tongue, liver, 
and kidney, but if spleen is available this 
single tissue will suffice.  Tissue samples 
should be kept as clean as possible and 
placed in a sealed plastic bag, such as a 
Whirl pac or Ziplock bag. 
  3. Keep all samples cold. DO NOT 
FREEZE. 
  4. Ship the sample overnight, using a well-
insulated package and cold packs.  Do not 
use wet ice for shipping.  Always include 
basic information such as the case history 
and name and telephone number of the 
submitter.  Again, consult the laboratory 
for specific instructions.  At SCWDS, for 
example, we are unable to receive packages 
over the weekend.  
 
Virus isolation is the only way to confirm a case 
of HD, but this can be a relatively slow process.  
Patience is required; you will be notified of the 
results by telephone as soon as they are available.  
Virus isolation attempts usually are completed 
within 2-3 weeks, but depending on the individual 
virus and sample quality, the period required to 
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isolate and identify the virus may range from as 
short as 10 days to as long as 1 month.  
Hopefully, you will not see any HD this year, but 
if you do, SCWDS will be more than happy to 
continue to assist you in your diagnostic needs.  




This year, SCWDS mailed a questionnaire on 
chronic wasting disease (CWD) along with the 
annual Hemorrhagic Disease Surveillance 
Questionnaire.  Respondents were asked to 
identify the numbers of cervids that had been 
identified as possible cases and were subjected to 
necropsy.  The CWD Surveillance Questionnaire 
revealed the "dawning of awareness" about this 
disease among wildlife managers and animal 
health officials.  Their responses indicated that 
only 26 animals had been examined last year 
because they fit the clinical picture of a CWD 
"target animal."  A CWD target animal is defined 
as follows:  The classic CWD "suspect" is a deer 
or elk 18 months of age or older that is 
emaciated and showing some combination of 
signs including abnormal behavior, increased 
salivation, tremors, stumbling, incoordination, 
difficulty in swallowing, excessive thirst, and 
excessive urination.  Considering that the 
definition of a CWD "target animal" corresponds 
well with the generic description of a "sick deer," 
26 cervids is too low.  Hopefully, the survey drew 
attention to the need to do better. 
 
Some good baseline data are being obtained.  We 
learned that individuals in 13 states in addition to 
Colorado and Wyoming had collected brains 
from 1,830 normal wild cervids for surveillance.  
Fortunately, the results for wild cervids have been 
negative outside the known endemic area in 
Colorado and Wyoming.  It is hoped that wildlife 
biologists and veterinary diagnosticians will make 
a greater effort to evaluate deer and elk that fit the 
"target profile" for CWD because this will be the 
most cost-effective method of surveillance.  
SCWDS would like to extend its thanks to the 
people who took the time to reply to the surveys.  
A copy of the Final Report is available upon 





Another CWD Case in Nebraska 
 
There has been a second confirmation of chronic 
wasting disease (CWD) in a captive elk in 
Nebraska.  This elk was in a captive herd of 
approximately 10 animals in Cheyenne County, 
near Scottsbluff.  It died on April 26, 1999, and 
the brain stem was submitted for testing.  
Histopathology and the tests for prion protein 
were positive.  The ranch has been placed under 
quarantine by the State Veterinarian's Office, and 
a herd plan is being developed which will require 
the herd to be under close observation by 
personnel with the Nebraska Department of 
Agriculture.  The Nebraska Game and Parks 
Commission will periodically check this herd and 
wild elk and deer in the vicinity for clinical signs 
of CWD.  All captive elk on this newly diagnosed 
farm came from a single source herd in Colorado, 
which was the same source herd where the first 
CWD elk in Nebraska (April 1998) was 
diagnosed (SCWDS BRIEFS Vol. 14, No. 1).  
There is an investigation underway to determine 
if other Nebraska elk herds may have received elk 
from this Colorado herd as well.  Fortunately, 
there were no movements of elk from the affected 
Nebraska herd since it was established in March 
1997.  Nebraska Game and Parks Commission 
personnel collected a wild elk that had been 
interacting with the captive elk through the fence; 
the brainstem from this wild elk was negative for 
CWD.  Nebraska has strengthened its legislation 
on captive cervids, and in the future, the State 
Veterinarian will be requiring reporting of all 
cervid mortality and CWD testing on all captive 
elk over 16 months of age that die.  (Prepared by 
Victor Nettles) 
 
Human Lyme Disease Vaccine  
 
SCWDS has received several calls from wildlife 
management agency administrators about the new 
human Lyme disease vaccine which recently has 
become available.  SCWDS personnel are not 
qualified to become involved in medical 
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treatment of humans, and we do not have a 
position on the appropriate use of this vaccine.  
However, this is an important question because 
the safety of agency personnel is a valid 
consideration and there is a substantial financial 
cost associated with the vaccine. 
The Centers for Disease Control and Prevention 
(CDC) recently published a brief report entitled 
Recommendations for the Use of Lyme Disease 
Vaccine (Morbidity and Mortality Weekly Report 
Vol. 48/No. RR-7, June 4, 1999).  This report 
summarized the scientific information pertaining 
to the vaccine and gives guidelines for when it 
should be deployed.  The human vaccine is called 
LYMErix®, and vaccination involves 3 injections 
at 0, 1, and 12 month intervals.  The vaccine 
efficacy data given indicate that there was a 49% 
protection rate in preventing definite Lyme 
disease diagnoses after 2 doses and a 76% 
protection after 3 doses.  No data are available on 
the duration of immunity and need for boosters.   
 
The report explains that different subpopulations 
of humans have different risks of exposure.  The 
CDC document states, "Most B. burgdorferi 
(Lyme disease organism) infections result from 
periresidential exposure to infected ticks during 
property maintenance, recreation and leisure 
activities."  It also states, "Persons who engage in 
outdoor occupations [e.g., forestry, wildlife and 
parks, etc.] in endemic areas might be at elevated 
risk for acquiring Lyme Disease."  In a 
cost-effectiveness estimate, it was stated that the 
"societal cost of vaccination [in this case the cost 
to the fish and wildlife agency] exceeds the cost 
of not vaccinating, unless the incidence of Lyme 
disease is greater than 1,973/100,000 
people/year."  The cost evaluation is based on the 
assumed vaccination cost of $100/person/ year.  
This incidence level is higher than the worst 
counties known in the endemic New England 
states.  However, these figures are based on the 
general public's exposure rate, which would 
include many people who may never see a tick, 
and a wildlife biologist or field technician may be 
at higher risk.  A Lyme disease Risk Map based 
on past experience is provided in the report.  For 
the Southeast, only Maryland and Virginia have 
counties in the high or moderate risk ratings; 
everything else received a low or minimal risk 
rating. 
 
In summary, the CDC's Recommendations does 
not seem to provide a complete endorsement for 
use of the vaccine, but instead, it provides the 
available scientific information so that people can 
make an informed choice.  We would suggest that 
wildlife managers seek advice from their state's 
public health department, their agency's health 
insurance provider, and knowledgeable 
physicians before starting a vaccination program 
for their personnel.  Consult the following CDC 




807a2.htm (Prepared by Victor Nettles) 
 
DEA Tightens Ketamine Use 
 
The Drug Enforcement Administration (DEA) of 
the U.S. Department of Justice has published a 
Final Rule placing ketamine into Schedule IIIN of 
the Controlled Substance Act as a non-narcotic 
controlled substance.  This Final Notice was 
published in the Federal Register (Vol. 64, No. 
133, July 13, 1999) and became effective July 2, 
1999.  Wildlife biologists and veterinarians often 
use ketamine (trade names Ketalar, Ketajet, 
Ketaset, and Vetalar) to immobilize wild animals, 
and this new regulation will have an impact on 
how they deploy the drug in the future.  The 
regulation was enacted because illicit human use 
of ketamine has become a serious problem.  
Street names for ketamine include "Special K" or 
"K."  Major veterinary organizations are 
supportive of the regulation. 
 
The new rules require that any person who 
manufactures, distributes, dispenses, imports, or 
exports ketamine must be registered with the 
DEA.  This applies also to people who are 
engaged in research or conduct instructional 
activities with ketamine.  Unless a person is 
registered with the DEA or has applied for 
registration before July 2, 1999, they must 
dispose of all stocks of ketamine according to 
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DEA guidelines.  Alternately, the stocks can be 
transferred to a person already registered with the 
DEA to possess Schedule III drugs.  Ketamine 
must be stored under appropriate security in 
conformance with DEA regulations, which means 
that it must be stored in a locked container.  
Furthermore, all packaged ketamine will be 
required to have the Schedule III controlled 
substance label by April 13, 2000.  Stringent use 
and inventory record keeping are required, and 
prescriptions that have been issued will be limited 
to 5 refills and will not be valid after January 13, 
2000. 
 
What does this mean for wildlife biologists?  
Manufacturers and distributors of ketamine can 
only sell to persons holding a DEA Schedule IIIN 
registration, so without a registration number 
ketamine cannot be purchased.  Persons who do 
research are eligible to apply for such a 
registration and, if registered, would be 
responsible for the drugs they purchase and 
administer.  Without such a personal registration, 
the wildlife biologist must obtain the ketamine 
from someone who is registered, most likely a 
veterinarian acting as an agent on behalf of the 
fish and wildlife agency.  Under the latter 
arrangement, the veterinarian is ultimately 
responsible for tracking the use of the drug even 
though the ketamine would be used in the field.  
Understandably, many veterinarians will be 
reluctant to take that responsibility.  People at the 
DEA have suggested the possibility of a third 
option that would be similar to what is done for 
animal control shelters.  Here, the state drug 
control agency must authorize the obtaining and 
dispensing of ketamine.  After the state authorizes 
this activity, the state wildlife agency can apply to 
the DEA to be permitted to purchase and use the 
drug under a mid-level practitioner's registration.  
For more information, the wildlife biologist 
should contact the DEA Registration Section (1-
800-882-9539 or 202-307-7255).  (Prepared by 
Victor Nettles)  
 
SCWDS Hosts ABLS Workshop 
 
Avian Brain Lesion Syndrome (ABLS) is a term 
used to refer to a mysterious neurologic disease 
that has been diagnosed in bald eagles, American 
coots, and several species of ducks (SCWDS 
BRIEFS Vol. 12, No. 4; Vol. 14, No. 3; and Vol. 
14, No. 4).  ABLS previously was called Coot 
and Eagle Brain Lesion Syndrome (CEBLS).  
The cause is unknown but is suspected to be a 
toxin.  The disease was first detected in a highly 
publicized die-off of bald eagles in Arkansas in 
1994 but now has been diagnosed in bald eagles 
and American coots in Arkansas, Georgia, North 
Carolina, and South Carolina, as well as in 
several species of ducks at 1 location in North 
Carolina. 
 
The original episodes of the disease were 
observed in Arkansas, and investigations were 
focused on a few reservoir lakes in that state that 
had affected birds.  In the past 2 years, diagnoses 
were made in 3 additional southeastern states, and 
therefore, the hypothesis that ABLS was due to 
some point-source problem unique to Arkansas 
has been abandoned.  Concomitant with this 
change in perspective has been the need to 
address this problem from a regional perspective 
as opposed to having a single state carry the lead.  
In May, the Arkansas Game and Fish 
Commission asked the Steering Committee of the 
Southeastern Cooperative Wildlife Disease Study 
(SCWDS) for assistance in promoting regional 
involvement, and SCWDS was encouraged to 
host a workshop to discuss ways for the states to 
proceed. 
 
SCWDS will host a Workshop on Avian Brain 
Lesion Syndrome that will be held on Thursday, 
August 26, 1999, at The University of Georgia's 
Center For Continuing Education in Athens, GA.  
There will be 3 objectives for the Workshop: 
  1. To provide field biologists and others with 
basic information about ABLS. 
  2. To receive information from the U.S. 
Department of the Interior (Fish and 
Wildlife Service and/or Biological 
Resources Division of the U.S. Geological 
Survey) on their approach to further 
investigation (plans being formulated now). 
 
SCWDS BRIEFS, July 1999, Vol. 15, No. 2 
 -6- 
  3. Discuss ways that state fish and wildlife 
agencies can contribute to the investigation 
to help resolve the problem. 
 
Invitations were sent to all state fish and wildlife 
agencies in the Southeast asking them to send 
their representatives to participate in this 
Workshop.  ABLS has implications for both 
game and non-game birds, and because the cause 
is unknown, wildlife agencies must be prepared to 
face speculation from both the scientific sector 
and the general public.  (Prepared by Victor 
Nettles) 
 
Harold M. Smith -- 1942-1999 
 
Dr. Harold M. Smith, Jr. (Lt. Col., Retired), 
former SCWDS Research Associate and graduate 
student, died July 25, 1999, as a result of 
complications following heart by-pass surgery.  
Harold was an active member of numerous 
professional and sportsmen's groups, and few 
could equal his enthusiasm and love for wildlife 
both from a vocational and an avocational 
perspective.  His death is a great loss to the 
veterinary profession, the wildlife profession, and 
his many friends throughout the country.  He will 
be greatly missed.  
 
Harold graduated from The University of 
Georgia's College of Veterinary Medicine in 1966 
and entered the U.S. Air Force Veterinary Corps 
shortly thereafter.  His first assignment was at 
Pease AFB, NH.  In 1969 Harold left the Air 
Force and entered private practice in Savannah, 
GA.  He returned to military service in 1974 as an 
Air Force veterinarian stationed at Camp 
Pendleton, CA. 
 
With his intense interest in wildlife medicine, 
Harold persuaded the Air Force to allow him to 
continue his educational pursuits, and in 1979 he 
entered a graduate program in wildlife 
parasitology with SCWDS.  During his research 
on the parasites of wild swine for his Master of 
Science degree, Harold acquired the affectionate 
nickname "Boss Hog" from his coworkers at 
SCWDS.   
 
While Harold was in the graduate program at 
SCWDS, the Air Force terminated its Veterinary 
Corps.  Undaunted, Harold simply joined the 
Army Veterinary Corps to continue his career!  
After a couple of years at Ft. Gordon, GA, Harold 
realized a life-long dream of living in Alaska.  He 
was assigned to Ft. Wainwright, AK, as an army 
veterinarian responsible for issues involving food 
safety, public health, and animal medicine.  
During his 5-year tour of duty in Alaska, much of 
his off-duty time was devoted to hunting and 
fishing in Alaska's wilds.  His wife Gee and son 
Canada shared equally in his Alaska experience, 
just as they did in all aspects of his life.  
(Submitted by Col. Paul L. Barrows, U.S. Army 
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Information presented in this Newsletter is not intended for citation in 
scientific literature.  Please contact the Southeastern Cooperative 
Wildlife Disease Study if citable information is needed. 
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Recent SCWDS Publications Available 
 
Below are some recent publications authored or co-authored by SCWDS staff.  If you would like to have a 
copy of any of these papers, fill out the request form and return it to us.   
 
____Abdy, M.J., E.W. Howerth, and D.E. Stallknecht.  1999.  Experimental infection of cattle with 
epizootic hemorrhagic disease virus.  American Journal of Veterinary Research 69(5): 621-626. 
 
____Brandsma, A.R., S.E. Little, J.M. Lockhart, W.R. Davidson, D.E. Stallknecht, and J.E. Dawson.  1999.  
Novel Ehrlichia organism (Richettsiales: Ehrlichieae) in white-tailed deer associated with lone star 
tick (Acari:  Ixodidae) parasitism.  Journal of Medical Entomology 36(2): 190-194. 
 
____Little, S.E., D.E. Stallknecht, J.M. Lockhart, J.E. Dawson, and W.R. Davidson.  1999.  Natural 
coinfection of a white-tailed deer (Odocoileus virginianus) population with three Ehrlichia.  Journal 
of Parasitology 84(5): 897-901. 
 
____Lockhart, J.M. and W.R. Davidson.  1999.  Evaluation of C3H/HeJ mice for xenodiagnosis of 
infection with Ehrlichia chaffeensis.  Journal of Veterinary Diagnostic Investigation 11: 55-59. 
 
____Stallknecht, D.E., E.W. Howerth, C.L. Reeves, and B.S. Seal.  1999.  Potential for contact and 
mechanical vector transmission of vesicular stomatitis virus New Jersey in pigs.  American Journal of 
Veterinary Research 60(1): 43-48. 
 
____Van Brackle, M.D., R.L. Marchinton, G.O. Ware, V.F. Nettles, S.B. Linhart, C.D. Ruth, and L.O. 
Rogers.  1995.  Oral biomarking of a supplementally-fed herd of free-ranging white-tailed deer.  
1995 Proceedings of the Southeastern Association of Fish and Wildlife Agencies, pp. 372-381. 
 
____Wlodkowski, J.C. and S.B Linhart.  1998.  Raccoon acceptance of a new coated capsule bait.  Wildlife 
Society Bulletin 26(3): 575-577. 
 
____Little, S.E. and E.W. Howerth.  1999.  Ehrlichia chaffeensis in archived tissues of a white-tailed deer.  
Journal of Wildlife Diseases 35: 596-599. 
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